{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:00:08Z","timestamp":1781208008890,"version":"3.54.1"},"reference-count":72,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from asymptomatic to life-threatening arrhythmias and progressive heart failure due to the extent and location of granulomatous inflammation in the myocardium. Advances in imaging techniques have played a pivotal role in the evaluation of CS because histological diagnoses obtained by myocardial biopsy tend to have lower sensitivity. The diagnosis of CS is challenging, and several approaches, notably those using positron emission tomography and cardiac magnetic resonance imaging (MRI), have been reported. Delayed-enhanced computed tomography (CT) may also be used for diagnosing CS in patients with MRI-incompatible devices and allows acceptable evaluation of myocardial hyperenhancement in such patients. This article reviews the advances in imaging techniques for the evaluation of CS.<\/jats:p>","DOI":"10.3390\/jcm10245808","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T01:28:11Z","timestamp":1639358891000},"page":"5808","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Advances in Diagnostic Imaging for Cardiac Sarcoidosis"],"prefix":"10.3390","volume":"10","author":[{"given":"Osamu","family":"Manabe","sequence":"first","affiliation":[{"name":"Department of Radiology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-0176","authenticated-orcid":false,"given":"Tadao","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-1975","authenticated-orcid":false,"given":"Satonori","family":"Tsuneta","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagara","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of Sarcoidosis and Its Management","volume":"385","author":"Drent","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_2","unstructured":"Statement on Sarcoidosis (1999). Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) Adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med., 160, 736\u2013755."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4070\/kcj.2021.0104","article-title":"The Role of Multimodality Imaging in Cardiac Sarcoidosis","volume":"51","author":"Manabe","year":"2021","journal-title":"Korean Circ. J."},{"key":"ref_5","unstructured":"Hiraga, H., Hiroe, M., and Iwai, K. (1993). Guidelines for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases, The Japanese Ministry of Health and Welfare. (In Japanese)."},{"key":"ref_6","unstructured":"(2007). Diagnostic Standard and Guidelines for Sarcoidosis. Jpn. J. Sarcoidosis Granulomatous Disord., 27, 89\u2013102. (In Japanese)."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2185\/jrm.2020-022","article-title":"Characteristics of patients with a diagnosis of sarcoidosis: A comparison of the 2006 and 2015 versions of diagnostic criteria for sarcoidosis in Japan","volume":"16","author":"Sakamoto","year":"2021","journal-title":"J. Rural. Med."},{"key":"ref_8","first-page":"2329","article-title":"JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis\u2014Digest Version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A Positive Endomyocardial Biopsy Result for Sarcoid Is Associated with Poor Prognosis in Patients with Initially Unexplained Cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1007\/s00330-017-4824-x","article-title":"Delayed Contrast-Enhanced Computed Tomography in Patients with Known or Suspected Cardiac Sarcoidosis: A Feasibility Study","volume":"27","author":"Aikawa","year":"2017","journal-title":"Eur. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Cardiac Magnetic Resonance (CMR) in Corticosteroid-Naive Patients with Conduction System Disease due to Cardiac Sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_13","first-page":"1414","article-title":"Recommendations for 18F-fluorodeoxyglucose Positron Emission Tomography Imaging for Diagnosis of Cardiac sarcoidosis-2018 Update: Japanese Society of Nuclear Cardiology Recommendations","volume":"26","author":"Kumita","year":"2019","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/RLU.0000000000003777","article-title":"What Is the Optimal Method on Myocardial Suppression in FDG PET\/CT Evaluation of Cardiac Sarcoidosis?","volume":"46","author":"Lu","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of Myocardial 18F-FDG Uptake through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet before FDG-PET\/CT for Evaluation of Patients with Suspected Cardiac Sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: The optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","article-title":"The Effects of 18-h Fasting with Low-Carbohydrate Diet Preparation on Suppressed Physiological Myocardial 18F-Fluorodeoxyglucose (FDG) Uptake and Possible Minimal Effects of Unfractionated Heparin Use in Patients with Suspected Cardiac Involvement Sarcoidosis","volume":"23","author":"Manabe","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_19","first-page":"1324","article-title":"Inter- and Intraobserver Agreement of 18F-FDG PET\/CT Image Interpretation in Patients Referred for Assessment of Cardiac Sarcoidosis","volume":"58","author":"Ohira","year":"2017","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic Performance of F-18 FDG PET for Detection of Cardiac Sarcoidosis; A Systematic Review and Meta-Analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients with Suspected Cardiac Sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12149-014-0860-7","article-title":"Right Ventricular 18F-FDG Uptake Is an Important Indicator for Cardiac Involvement in Patients with Suspected Cardiac Sarcoidosis","volume":"28","author":"Manabe","year":"2014","journal-title":"Ann. Nucl. Med."},{"key":"ref_23","first-page":"2135","article-title":"18F-FDG Uptake of the Right Ventricle Is an Important Predictor of Histopathologic Diagnosis by Endomyocardial Biopsy in Patients with Cardiac Sarcoidosis","volume":"27","author":"Omote","year":"2020","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative Analysis of Myocardial 18F-fluorodeoxyglucose Uptake by PET\/CT for Detection of Cardiac Sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-Treatment Myocardial 18FDG Uptake Predicts Response to Immunosuppression in Patients with Cardiac Sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"J. Am. Coll. Cardiol. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative Interpretation of FDG PET\/CT with Myocardial Perfusion Imaging Increases Diagnostic Information in the Evaluation of Cardiac Sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"ref_27","first-page":"166","article-title":"Reduction in 18F-fluorodeoxyglucose Uptake on Serial Cardiac Positron Emission Tomography Is Associated with Improved Left Ventricular Ejection Fraction in Patients with Cardiac Sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous Myocardial FDG Uptake and the Disease Activity in Cardiac Sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"J. Am. Coll. Cardiol. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ehjci\/jex175","article-title":"Heterogeneity of Myocardial 2-[18F]Fluoro-2-Deoxy-D-Glucose Uptake Is a Typical Feature in Cardiac Sarcoidosis: A Study of 231 Patients","volume":"19","author":"Schildt","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jcmg.2019.11.021","article-title":"Prognostic Value of 18F-FDG PET Using Texture Analysis in Cardiac Sarcoidosis","volume":"13","author":"Manabe","year":"2020","journal-title":"J. Am. Coll. Cardiol. Imaging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-018-4195-9","article-title":"Use of 18F-FDG PET\/CT Texture Analysis to Diagnose Cardiac Sarcoidosis","volume":"46","author":"Manabe","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-019-04577-0","article-title":"Detailed Visualization of the Right and Left Ventricular, Left Atrial, and Epicardial Involvement of Cardiac Sarcoidosis with Novel Semiconductor PET\/CT","volume":"47","author":"Manabe","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12149-020-01519-x","article-title":"Recent Advances in Cardiac Positron Emission Tomography for Quantitative Perfusion Analyses and Molecular Imaging","volume":"34","author":"Manabe","year":"2020","journal-title":"Ann. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical Localization of Somatostatin Receptor sst2A in Sarcoid Granulomas","volume":"29","author":"Hofland","year":"1999","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The Utility of PET\/CT with 68Ga-DOTATOC in Sarcoidosis: Comparison with 67Ga-Scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann. Nucl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin Receptor Based PET\/CT in Patients with the Suspicion of Cardiac Sarcoidosis: An Initial Comparison to Cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"ref_38","first-page":"329","article-title":"18F-fluoromisonidazole (FMISO) PET May Have the Potential to Detect Cardiac Sarcoidosis","volume":"24","author":"Manabe","year":"2017","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_39","first-page":"2141","article-title":"18F-FMISO PET\/CT Detects Hypoxic Lesions of Cardiac and Extra-Cardiac Involvement in Patients with Sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative Evaluation of 18F-FLT and 18F-FDG for Detecting Cardiac and Extra-Cardiac Thoracic Involvement in Patients with Newly Diagnosed Sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging Cardiac Sarcoidosis with FLT-PET Compared with FDG\/Perfusion-PET: A Prospective Pilot Study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0000000000000808","article-title":"Detection of early phenotype cardiac sarcoidosis by cardiovascular magnetic resonance","volume":"27","author":"Levin","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of Myocardial Damage in Patients with Sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e011253","DOI":"10.1161\/JAHA.118.011253","article-title":"Myocardial Involvement in Patients with Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images from Autopsy or Cardiac Transplantation Cases","volume":"8","author":"Okasha","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients with Suspected Cardiac Sarcoidosis Is Associated with Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7457369","DOI":"10.1155\/2018\/7457369","article-title":"Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can. Respir. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of Known or Suspected Cardiac Sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic Value of Myocardial Scarring on CMR in Patients with Cardiac Sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive Late Gadolinium Enhancement on Cardiovascular Magnetic Resonance Predicts Adverse Outcomes and Lack of Improvement in LV Function After Steroid Therapy in Cardiac Sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ejrad.2013.06.005","article-title":"T2-Weighted Imaging of the Heart--A Pictorial Review","volume":"82","author":"Mirakhur","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e001728","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-Weighted Short-Tau-Inversion-Recovery Imaging Reflects Disease Activity of Cardiac Sarcoidosis","volume":"8","author":"Aoki","year":"2021","journal-title":"Open Heart"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/a-1174-0537","article-title":"Myocardial Mapping in Systemic Sarcoidosis: A Comparison of Two Measurement Approaches","volume":"193","author":"Dabir","year":"2021","journal-title":"Rofo"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"20190836","DOI":"10.1259\/bjr.20190836","article-title":"Positron Emission Tomography\/MRI for Cardiac Diseases Assessment","volume":"93","author":"Manabe","year":"2020","journal-title":"Br. J. Radiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid Magnetic Resonance Imaging and Positron Emission Tomography with Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same Day Comparison of PET\/CT and PET\/MR in Patients with Cardiac Sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic Accuracy and Prognostic Value of Simultaneous Hybrid 18F-fluorodeoxyglucose Positron Emission Tomography\/Magnetic Resonance Imaging in Cardiac Sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Greulich, S., Gatidis, S., Gr\u00e4ni, C., Blankstein, R., Glatthaar, A., Mezger, K., M\u00fcller, K.A.L., Castor, T., Mahrholdt, H., and H\u00e4ntschel, M. (2021). Hybrid Cardiac Magnetic Resonance\/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active from Chronic Cardiac Sarcoidosis. JACC Cardiovasc. Imaging, in press.","DOI":"10.1016\/j.jcmg.2021.08.018"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of Necropsy Findings in Patients with Sarcoidosis Dying Suddenly from Cardiac Sarcoidosis Versus Dying Suddenly from Other Causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/echo.14886","article-title":"Speckle Tracking Echocardiography Can Predict Subclinical Myocardial Involvement in Patients with Sarcoidosis: A Meta-Analysis","volume":"37","author":"Barssoum","year":"2020","journal-title":"Echocardiography"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1531.e9","DOI":"10.1016\/j.cjca.2013.02.023","article-title":"Improved Myocardial Strain Measured by Strain-Encoded Magnetic Resonance Imaging in a Patient with Cardiac Sarcoidosis","volume":"29","author":"Nakano","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/a-0598-5099","article-title":"Diagnostic Value of Cardiac Magnetic Resonance Strain Analysis for Detection of Cardiac Sarcoidosis","volume":"190","author":"Dabir","year":"2018","journal-title":"Rofo"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","article-title":"Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients with Sarcoidosis","volume":"13","author":"Velangi","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Elwazir, M.Y., Bird, J.G., Abouezzeddine, O.F., Chareonthaitawee, P., Blauwet, L.A., Collins, J.D., Gibbons, R.J., Rodriguez-Porcel, M., Kamal, H.M., and Abdellah, A.T. (2021). Performance of Cardiac PET\/CT with and without Phase Analysis for Detection of Scar in Cardiac Sarcoidosis: Comparison to Cardiac Magnetic Resonance Imaging. J. Nucl. Cardiol., in press.","DOI":"10.1007\/s12350-020-02473-x"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12350-019-01660-9","article-title":"Prognostic Value of Phase Analysis on Gated Single Photon Emission Computed Tomography in Patients with Cardiac Sarcoidosis","volume":"28","author":"Koyanagawa","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.104.529511","article-title":"Characterization of Acute and Chronic Myocardial Infarcts by Multidetector Computed Tomography: Comparison with Contrast-Enhanced Magnetic Resonance","volume":"113","author":"Gerber","year":"2006","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s12350-019-01692-1","article-title":"Cardiac Sarcoidosis Mimicking Myocardial Infarction: A Comprehensive Evaluation Using Computed Tomography and Positron Emission Tomography","volume":"27","author":"Aikawa","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2471070332","article-title":"Reperfused Myocardial Infarction: Contrast-Enhanced 64-Section CT in Comparison to MR Imaging","volume":"247","author":"Nieman","year":"2008","journal-title":"Radiology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1148\/radiol.2018172523","article-title":"Myocardial Delayed Enhancement CT for the Evaluation of Heart Failure: Comparison to MRI","volume":"288","author":"Ohta","year":"2018","journal-title":"Radiology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11604-020-01086-1","article-title":"Texture Analysis of Delayed Contrast-Enhanced Computed Tomography to Diagnose Cardiac Sarcoidosis","volume":"39","author":"Tsuneta","year":"2021","journal-title":"Jpn. J. Radiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5808\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:45:50Z","timestamp":1760168750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,11]]},"references-count":72,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jcm10245808"],"URL":"https:\/\/doi.org\/10.3390\/jcm10245808","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,11]]}}}